Real-world treatment patterns and outcomes of patients with advanced renal cell carcinoma (aRCC) treated with first-line (1L) axitinib + pembrolizumab therapy

Data sources

• Data source(s), other:
  Primary data on physicians’ treatment management approaches will be collected via a one-time physician survey. Retrospective patient data will be abstracted and entered into an electronic case report form by patients’ treating physicians or another physician in that patient’s treating practice within the oncology network. The source documents are the patient chart/medical record data housed within the electronic health records (EHRs) and accessed by the participating providers.
• Data sources (types):
  Electronic healthcare records (EHR)

  Patient surveys

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No